Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring

  • STATUS
    Recruiting
  • End date
    Feb 5, 2022
  • participants needed
    120
  • sponsor
    Amgen
Updated on 26 January 2021
Investigator
Amgen Call Center
Primary Contact
Research Site (2.7 mi away) Contact
+3 other location
ejection fraction
heart failure
chronic heart failure

Summary

A study evaluating the impact of remotely collected data, measured using digital technologies, on the use of guideline-recommended heart failure therapy in adult participants with heart failure.

Details
Treatment Standard of Care, Biobeat Wrist Watch
Clinical Study IdentifierNCT04292275
SponsorAmgen
Last Modified on26 January 2021

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 85 yrs?
Gender: Male or Female
Do you have any of these conditions: Heart disease or Cardiac Disease or Congestive Heart Failure or Heart failure?
Do you have any of these conditions: Congestive Heart Failure or Cardiac Disease or Heart failure or congestive heart disease or cardiac failure or Heart disease?
Do you have any of these conditions: Cardiac Disease or Congestive Heart Failure or cardiac failure or congestive heart disease or Heart failure or Heart disease?
History of chronic heart failure
Ejection fraction equal to or below 40%
New York Heart Association (NYHA) class II to class III
Enrollment during or within 30 days after a hospitalization, emergency department, or urgent, unscheduled clinic/office visit with primary diagnosis of heart failure

Exclusion Criteria

Has received a major organ transplant (e.g., lung, liver, heart, bone marrow, kidney)
Currently in an investigational device or drug study
Unwilling or unable to wear a digital wrist watch device for measuring blood pressure and other parameters during waking hours
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet